Boc-L-1,2,3,4-tetrahydronorharman-3-carboxylic acid, 98.0%, 5g

dNTP-Set 1, 4 x 25 µmol (250 µl), 100 mM

(1s,2R,3r,8S)-4-(methoxycarbonyl)cubane-1-carboxylic acid, 97.0%, 1g

2'-O-METHYL-2,6-DIAMINOPURINE-RIBOSIDE, 95.0%, 1g

2-((Tert-butoxycarbonyl)amino)-3,4-dimethylbenzoic acid, 97%, 5g

3-(3-Methylisoxazol-5-yl)propan-1-ol, 95.0%, 1g

5-Hydroxy-2-methylbenzofuran-3-carboxylic acid, 97%, 1g

TOLTRAZURIL, 98%, 10g

3-(2-aminoethyl)-1,3-oxazolidin-2-one hydrochloride, 95.0%, 1g

2-Chloro-5-(2,2,2-trifluoroethyl)pyridine, 95.0%, 250mg

2-Butyl-2-azatricyclo[6.3.1.0,4,12]dodeca-1(12),4,6,8,10-pentaen-3-one, 97%, 250mg

4-iso-Propyl-2-(trifluoromethyl)aniline, 250mg

3-(2-Chlorophenyl)acrylaldehyde, 95.0%, 5g